Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125782781 | 12578278 | 1 | I | 2008 | 20160708 | 20160721 | 20160721 | EXP | BR-ALVOGEN-2016-ALVOGEN-026376 | ALVOGEN | 59.00 | YR | M | Y | 0.00000 | 20160721 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125782781 | 12578278 | 1 | PS | ATENOLOL. | ATENOLOL | 1 | Oral | U | 18240 | 50 | MG | BID | |||||||
| 125782781 | 12578278 | 2 | SS | BRILINTA | TICAGRELOR | 1 | Oral | Y | 0 | 90 | MG | BID | |||||||
| 125782781 | 12578278 | 3 | SS | PROPATYLNITRATE | PROPATYL NITRATE | 1 | U | 0 | |||||||||||
| 125782781 | 12578278 | 4 | C | LOSARTAN. | LOSARTAN | 1 | 0 | 20 | MG | BID | |||||||||
| 125782781 | 12578278 | 5 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | 0 | BID | |||||||||||
| 125782781 | 12578278 | 6 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 0 | 850 | MG | BID | |||||||||
| 125782781 | 12578278 | 7 | C | GLIBENCLAMIDE | GLYBURIDE | 1 | 0 | 20 | MG | BID | |||||||||
| 125782781 | 12578278 | 8 | SS | PROPATYLNITRATE | PROPATYL NITRATE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125782781 | 12578278 | 1 | Hypertension |
| 125782781 | 12578278 | 2 | Infarction |
| 125782781 | 12578278 | 3 | Product used for unknown indication |
| 125782781 | 12578278 | 4 | Product used for unknown indication |
| 125782781 | 12578278 | 5 | Product used for unknown indication |
| 125782781 | 12578278 | 6 | Diabetes mellitus |
| 125782781 | 12578278 | 7 | Diabetes mellitus |
| 125782781 | 12578278 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125782781 | 12578278 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125782781 | 12578278 | Coronary artery occlusion | |
| 125782781 | 12578278 | Dyspnoea | |
| 125782781 | 12578278 | Fatigue | |
| 125782781 | 12578278 | Intentional product misuse | |
| 125782781 | 12578278 | Myocardial infarction | |
| 125782781 | 12578278 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125782781 | 12578278 | 1 | 2008 | 201604 | 0 | |
| 125782781 | 12578278 | 2 | 20160515 | 201606 | 0 | |
| 125782781 | 12578278 | 3 | 2008 | 0 | ||
| 125782781 | 12578278 | 4 | 2008 | 0 | ||
| 125782781 | 12578278 | 5 | 2008 | 0 | ||
| 125782781 | 12578278 | 6 | 2008 | 0 | ||
| 125782781 | 12578278 | 7 | 2008 | 0 | ||
| 125782781 | 12578278 | 8 | 201606 | 0 |